Arrhythmia Atrial fibrillation Bradysystolic

Atrial fibrillation bradysystolic: symptoms, causes and treatment

Bradysystolic atrial fibrillation (or atrial fibrillation) is a heart disease in which the heart begins to beat irregularly, with a frequency of less than 60 beats per minute. This form of arrhythmia is the most dangerous, as it can lead to the development of serious complications such as cardiogenic shock or cardiac arrest.

Symptoms of atrial fibrillation may include palpitations, weakness, dizziness, loss of consciousness, or chest pain. In some cases, symptoms may not be obvious, especially in older people.

The causes of atrial fibrillation bradysystolic can be different. This may be due to age, heredity, heart disease (such as coronary artery disease or hypertrophic cardiomyopathy), elevated levels of potassium in the blood, or the use of certain medications.

Various methods can be used to diagnose bradysystolic atrial fibrillation, including ECG, Holter monitoring and electrophysiological studies.

Treatment for atrial fibrillation may include drug therapy such as antiarrhythmic drugs or beta blockers. In some cases, electrical cardioversion or pacemaker implantation may be required.

Overall, bradysystolic atrial fibrillation is a serious heart condition that can lead to serious complications. If symptoms appear, you should consult a doctor for diagnosis and treatment. Seeking medical help early can help prevent serious complications and improve the prognosis of the disease.

Atrial fibrillation, arrhythmia - see Bradyarrhythmias.

ARRHYTHMIA, synonyms: arrhythmopathy, dysrhythmia - a violation of the frequency, rhythm and sequence of excitation and contraction of the heart or impulses passing through its conduction system.

Causes of cardiomyopathy: coronary heart disease, chronic rheumatic heart disease, circulatory failure, digitalis intoxication. Bradyseistolic arrhythmias develop with infectious myocarditis, decompensated damage to the left atrium valve (mitral valve defects), as well as against the background of chronic heart failure with blood stagnation in the pulmonary circulation. Drug-induced bradystenocardia more often develops in patients with orthostatic hypotension and can be combined with hemodynamically significant arrhythmias.